Adjunctive with versus without intravitreal bevacizumab injection before ahmed glaucoma valve implantation in the treatment of neovascular glaucoma

Chinese Medical Journal

Volumn 126, Issue 8, 2013, Pages 1412-1417

  Zhou, Min Wen ^a,b   Wang, Wei ^a   Huang, Wen Bin ^a,b   Chen, Shi Da ^a,b   Li, Xing Yi ^a,b   Gao, Xin Bao ^a,b   Zhang, Xiu Lan ^a,b  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Ahmed glaucoma valve implantation; Intravitreal bevacizumab injection; Neovascular glaucoma

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BEVACIZUMAB; CARBONATE DEHYDRATASE INHIBITOR; MITOMYCIN; PRANOPROFEN; PREDNISOLONE ACETATE;

ADULT; ANTERIOR EYE CHAMBER DISEASE; ARTICLE; CHOROID DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; GLAUCOMA DRAINAGE IMPLANT; HUMAN; HYPERTENSION; HYPHEMA; HYPOTONY MACULOPATHY; INTRAOCULAR PRESSURE; MALE; NEOVASCULAR GLAUCOMA; OCULOPLETHYSMOGRAPHY; ORBIT CYST; POLYGLACTIN SUTURE; POST TREATMENT SURVIVAL; POSTOPERATIVE COMPLICATION; RETROSPECTIVE STUDY; TREATMENT OUTCOME; VISUAL ACUITY;

ADULT; AGED; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; FEMALE; GLAUCOMA DRAINAGE IMPLANTS; GLAUCOMA, NEOVASCULAR; HUMANS; INTRAOCULAR PRESSURE; INTRAVITREAL INJECTIONS; MALE; MIDDLE AGED; PROSTHESIS IMPLANTATION; RETROSPECTIVE STUDIES; VISUAL ACUITY;

EID: 84876377295     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.20130011     Document Type: Article

References (30)

1. Shazly TA, Latina MA. Neovascular glaucoma: etiology, diagnosis and prognosis. Semin Ophthalmol 2009; 24: 113-121.
2. Tzamalis A, Pham DT, Wirbelauer C. Diode laser cyclophotocoagulation versus cyclocryotherapy in the treatment of refractory glaucoma. Eur J Ophthalmol 2011; 21: 589-596.
3. Fong AW, Lee GA, O'Rourke P, Thomas R. Management of neovascular glaucoma with transscleral cyclophotocoagulation with diode laser alone versus combination transscleral cyclophotocoagulation with diode laser and intravitreal bevacizumab. Clin Experiment Ophthalmol 2011; 39: 318-323.
4. Netland PA. The Ahmed glaucoma valve in neovascular glaucoma (An AOS Thesis). Trans Am Ophthalmol Soc 2009; 107: 325-342.
5. Saito Y, Higashide T, Takeda H, Ohkubo S, Sugiyama K. Beneficial effects of preoperative intravitreal bevacizumab on trabeculectomy outcomes in neovascular glaucoma. Acta Ophthalmol 2010; 88: 96-102.
6. Takihara Y, Inatani M, Fukushima M, Iwao K, Iwao M, Tanihara H. Trabeculectomy with mitomycin C for neovascular glaucoma: prognostic factors for surgical failure. Am J Ophthalmol 2009; 147: 911-918.
7. Park UC, Park KH, Kim DM, Yu HG. Ahmed glaucoma valve implantation for neovascular glaucoma after vitrectomy for proliferative diabetic retinopathy. J Glaucoma 2011; 20: 433-438.
8. Yasuda S, Kachi S, Kondo M, Ushida H, Uetani R, Terui T, et al. Significant correlation between electroretinogram parameters and ocular vascular endothelial growth factor concentration in central retinal vein occlusion eyes. Invest Ophthalmol Vis Sci 2011; 52: 5737-5742.
9. Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocrine Reviews 2004; 25: 581-611.
10. Yazdani S, Hendi K, Pakravan M, Mahdavi M, Yaseri M. Intravitreal bevacizumab for neovascular glaucoma: a randomized controlled trial. J Glaucoma 2009; 18: 632-637.
11. Kahook MY, Schuman JS, Noecker RJ. Needle bleb revision of encapsulated filtering bleb with bevacizumab. Ophthalmic Surg Lasers Imaging 2006; 37: 148-150.
12. Eid TM, Radwan A, El-Manawy W, El-Hawary I. Intravitreal bevacizumab and aqueous shunting surgery for neovascular glaucoma: safety and efficacy. Can J Ophthalmol 2009; 44: 451-456.
13. Takihara Y, Inatani M, Kawaji T, Fukushima M, Iwao K, Iwao M, et al. Combined intravitreal bevacizumab and trabeculectomy with mitomycin C versus trabeculectomy with mitomycin C alone for neovascular glaucoma. J Glaucoma 2011; 20: 196-201.
14. Marey HM, Ellakwa AF. Intravitreal bevacizumab with or without mitomycin C trabeculectomy in the treatment of neovascular glaucoma. Clin Ophthalmol. 2011; 5: 841-845.
15. Ma KT, Yang JY, Kim JH, Kim NR, Hong S, Lee ES, et al. Surgical results of Ahmed valve implantation with intraoperative bevacizumab injection in patients with neovascular glaucoma. J Glaucoma 2012; 21: 331-336.
16. Souza C, Tran DH, Loman J, Law SK, Coleman AL, Caprioli J. Long-term outcomes of Ahmed glaucoma valve implantation in refractory glaucomas. Am J Ophthalmol 2007; 144: 893-900.
17. Wilson MR, Mendis U, Smith SD, Paliwal A. Ahmed glaucoma valve implant vs. trabeculectomy in the surgical treatment of glaucoma: a randomized clinical trial. Am J Ophthalmol 2000; 130: 267-273.
18. Gedde SJ, Schiffman JC, Feuer WJ, Herndon LW, Brandt JD, Budenz DL. Treatment outcomes in the Tube Versus Trabeculectomy (TVT) study after five years of follow-up. Am J Ophthalmol 2012; 153: 789-803.
19. Sivak-Callcott JA, O'Day DM, Gass JD, Tsai JC. Evidence-based recommendations for the diagnosis and treatment of neovascular glaucoma. Ophthalmology 2001; 108: 1767-1777, 1800.
20. Yalvac IS, Eksioglu U, Satana B, Duman S. Long-term results of Ahmed glaucoma valve and Molteno implant in neovascular glaucoma. Eye 2007; 21: 65-70.
21. Netland PA, Ishida K, Boyle JW. The Ahmed Glaucoma Valve in patients with and without neovascular glaucoma. J Glaucoma 2010; 19: 581-586.
22. Shen CC, Salim S, Du H, Netland PA. Trabeculectomy versus Ahmed Glaucoma Valve implantation in neovascular glaucoma. Clin Ophthalmol 2011; 5: 281-286.
23. Yildirim N, Yalvac IS, Sahin A, Ozer A, Bozca T. A comparative study between diode laser cyclophotocoagulation and the Ahmed glaucoma valve implant in neovascular glaucoma: a long-term follow-up. J Glaucoma 2009; 18: 192-196.
24. Canut MI, Alvarez A, Nadal J, Abreu R, Abreu JA, Pulido JS. Anterior segment changes following intravitreal bevacizumab injection for treatment of neovascular glaucoma. Clin Ophthalmol 2011; 5: 715-719.
25. Davidorf FH, Mouser JG, Derick RJ. Rapid improvement of rubeosis iridis from a single bevacizumab (Avastin) injection. Retina 2006; 26: 354-356.
26. Iliev ME, Domig D, Wolf-Schnurrbursch U, Wolf S, Sarra GM. Intravitreal bevacizumab (Avastin) in the treatment of neovascular glaucoma. Am J Ophthalmol 2006; 142: 1054-1056.
27. Yazdani S, Hendi K, Pakravan M. Intravitreal bevacizumab (Avastin) injection for neovascular glaucoma. J Glaucoma 2007; 16: 437-439.
28. Wakabayashi T, Oshima Y, Sakaguchi H, Ikuno Y, Miki A, Gomi F, et al. Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases. Ophthalmology 2008; 115: 1571-1581.
29. Lupinacci AP, Calzada JI, Rafieetery M, Charles S, Netland PA. Clinical outcomes of patients with anterior segment neovascularization treated with or without intraocular bevacizumab. Adv Ther 2009; 26: 208-216.
30. Every SG, Molteno AC, Bevin TH, Herbison P. Long-term results of Molteno implant insertion in cases of neovascular glaucoma. Arch Ophthalmol 2006; 124: 355-360.